501 related articles for article (PubMed ID: 27888296)
1. Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology.
Dzamko N; Gysbers A; Perera G; Bahar A; Shankar A; Gao J; Fu Y; Halliday GM
Acta Neuropathol; 2017 Feb; 133(2):303-319. PubMed ID: 27888296
[TBL] [Abstract][Full Text] [Related]
2. Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.
Doorn KJ; Moors T; Drukarch B; van de Berg WDj; Lucassen PJ; van Dam AM
Acta Neuropathol Commun; 2014 Aug; 2():90. PubMed ID: 25099483
[TBL] [Abstract][Full Text] [Related]
3. Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2.
Xia Y; Zhang G; Kou L; Yin S; Han C; Hu J; Wan F; Sun Y; Wu J; Li Y; Huang J; Xiong N; Zhang Z; Wang T
Brain; 2021 Aug; 144(7):2024-2037. PubMed ID: 33792662
[TBL] [Abstract][Full Text] [Related]
4. A small molecule toll-like receptor antagonist rescues α-synuclein fibril pathology.
Chedid J; Labrador-Garrido A; Zhong S; Gao J; Zhao Y; Perera G; Kim WS; Halliday GM; Dzamko N
J Biol Chem; 2022 Aug; 298(8):102260. PubMed ID: 35841928
[TBL] [Abstract][Full Text] [Related]
5. Neuroinflammation and protein pathology in Parkinson's disease dementia.
Kouli A; Camacho M; Allinson K; Williams-Gray CH
Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease.
Drouin-Ouellet J; St-Amour I; Saint-Pierre M; Lamontagne-Proulx J; Kriz J; Barker RA; Cicchetti F
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522431
[TBL] [Abstract][Full Text] [Related]
7. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.
Watson MB; Richter F; Lee SK; Gabby L; Wu J; Masliah E; Effros RB; Chesselet MF
Exp Neurol; 2012 Oct; 237(2):318-34. PubMed ID: 22750327
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation.
Kim C; Spencer B; Rockenstein E; Yamakado H; Mante M; Adame A; Fields JA; Masliah D; Iba M; Lee HJ; Rissman RA; Lee SJ; Masliah E
Mol Neurodegener; 2018 Aug; 13(1):43. PubMed ID: 30092810
[TBL] [Abstract][Full Text] [Related]
9. TLR2 and TLR4 in Parkinson's disease pathogenesis: the environment takes a toll on the gut.
Gorecki AM; Anyaegbu CC; Anderton RS
Transl Neurodegener; 2021 Nov; 10(1):47. PubMed ID: 34814947
[TBL] [Abstract][Full Text] [Related]
10. Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells.
Kim C; Kwon S; Iba M; Spencer B; Rockenstein E; Mante M; Adame A; Shin SJ; Fields JA; Rissman RA; Lee SJ; Masliah E
Exp Mol Med; 2021 Feb; 53(2):281-290. PubMed ID: 33594256
[TBL] [Abstract][Full Text] [Related]
11. Neuroinflammation in Parkinson's Disease and its Treatment Opportunities.
Çınar E; Tel BC; Şahin G
Balkan Med J; 2022 Sep; 39(5):318-333. PubMed ID: 36036436
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein induces prodromal symptoms of Parkinson's disease via activating TLR2/MyD88/NF-κB pathway in Schwann cells of vagus nerve in a rat model.
Cheng Y; Tong Q; Yuan Y; Song X; Jiang W; Wang Y; Li W; Li Y; Zhang K
J Neuroinflammation; 2023 Feb; 20(1):36. PubMed ID: 36788559
[TBL] [Abstract][Full Text] [Related]
13. Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain-derived α-synuclein.
Limegrover CS; Yurko R; Izzo NJ; LaBarbera KM; Rehak C; Look G; Rishton G; Safferstein H; Catalano SM
J Neurosci Res; 2021 Apr; 99(4):1161-1176. PubMed ID: 33480104
[TBL] [Abstract][Full Text] [Related]
14. Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy.
Kim C; Rockenstein E; Spencer B; Kim HK; Adame A; Trejo M; Stafa K; Lee HJ; Lee SJ; Masliah E
Cell Rep; 2015 Oct; 13(4):771-782. PubMed ID: 26489461
[TBL] [Abstract][Full Text] [Related]
15. TLR4 and TLR2 activation is differentially associated with age during Parkinson's disease.
Rocha Sobrinho HMD; Silva DJD; Gomides LF; Dorta ML; Oliveira MAP; Ribeiro-Dias F
Immunol Invest; 2018 Jan; 47(1):71-88. PubMed ID: 29077524
[TBL] [Abstract][Full Text] [Related]
16. Extracellular α-synuclein--a possible initiator of inflammation in Parkinson's disease.
Ren WQ; Tian ZM; Yin F; Sun JZ; Zhang JN
Pharmazie; 2016 Feb; 71(2):51-5. PubMed ID: 27004367
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
[TBL] [Abstract][Full Text] [Related]
18. Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease.
Guo M; Wang J; Zhao Y; Feng Y; Han S; Dong Q; Cui M; Tieu K
Brain; 2020 May; 143(5):1476-1497. PubMed ID: 32355963
[TBL] [Abstract][Full Text] [Related]
19. Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.
Codolo G; Plotegher N; Pozzobon T; Brucale M; Tessari I; Bubacco L; de Bernard M
PLoS One; 2013; 8(1):e55375. PubMed ID: 23383169
[TBL] [Abstract][Full Text] [Related]
20. S-Nitrosylation of p62 Inhibits Autophagic Flux to Promote α-Synuclein Secretion and Spread in Parkinson's Disease and Lewy Body Dementia.
Oh CK; Dolatabadi N; Cieplak P; Diaz-Meco MT; Moscat J; Nolan JP; Nakamura T; Lipton SA
J Neurosci; 2022 Apr; 42(14):3011-3024. PubMed ID: 35169022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
